Autolus Therapeutics Stock Forecast - Period Momentum Indicator

AUTL Stock  USD 4.01  0.01  0.25%   
Autolus Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Autolus Therapeutics stock prices and determine the direction of Autolus Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Autolus Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Autolus Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Autolus Therapeutics' systematic risk associated with finding meaningful patterns of Autolus Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Autolus Therapeutics to cross-verify your projections.
For more information on how to buy Autolus Stock please use our How to buy in Autolus Stock guide.
  
Payables Turnover is expected to rise to 91.78 this year, although the value of Inventory Turnover is projected to rise to (0.25). . Common Stock Shares Outstanding is expected to rise to about 210 M this year, although the value of Net Loss will most likely fall to (54.7 M).

Open Interest Against 2024-05-17 Autolus Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Autolus Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Autolus Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Autolus Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Autolus Therapeutics' open interest, investors have to compare it to Autolus Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Autolus Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Autolus. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
On April 1, 2022 Autolus Therapeutics had Period Momentum Indicator of 0.3.
Most investors in Autolus Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Autolus Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Autolus Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Momentum indicator evaluates the difference between todays closing price and the close price n periods ago. It is the velocity with which the price is rising or falling. It also reflects how aggressively the asset is purchased or sold by the public.
Check Autolus Therapeutics VolatilityBacktest Autolus TherapeuticsInformation Ratio  
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
Compare Autolus Therapeutics to competition

Other Forecasting Options for Autolus Therapeutics

For every potential investor in Autolus, whether a beginner or expert, Autolus Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Autolus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Autolus. Basic forecasting techniques help filter out the noise by identifying Autolus Therapeutics' price trends.

View Autolus Therapeutics Related Equities

 Risk & Return  Correlation

Autolus Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Autolus Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Autolus Therapeutics' current price.

Autolus Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Autolus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Autolus Therapeutics shares will generate the highest return on investment. By undertsting and applying Autolus Therapeutics stock market strength indicators, traders can identify Autolus Therapeutics entry and exit signals to maximize returns.

Autolus Therapeutics Risk Indicators

The analysis of Autolus Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Autolus Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting autolus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Autolus Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Autolus Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Autolus Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Autolus Stock

  0.81ELAN Elanco Animal Health Financial Report 14th of May 2024 PairCorr

Moving against Autolus Stock

  0.65ACB Aurora Cannabis Sell-off TrendPairCorr
  0.57HCM HUTCHMED DRCPairCorr
  0.54CGC Canopy Growth Corp Financial Report 27th of June 2024 PairCorr
  0.45FLGC Flora Growth Corp Financial Report 20th of May 2024 PairCorr
The ability to find closely correlated positions to Autolus Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Autolus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Autolus Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Autolus Therapeutics to buy it.
The correlation of Autolus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Autolus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Autolus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Autolus Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Autolus Therapeutics is a strong investment it is important to analyze Autolus Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Autolus Therapeutics' future performance. For an informed investment choice regarding Autolus Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Autolus Therapeutics to cross-verify your projections.
For more information on how to buy Autolus Stock please use our How to buy in Autolus Stock guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Autolus Stock analysis

When running Autolus Therapeutics' price analysis, check to measure Autolus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autolus Therapeutics is operating at the current time. Most of Autolus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Autolus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autolus Therapeutics' price. Additionally, you may evaluate how the addition of Autolus Therapeutics to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Fundamental Analysis
View fundamental data based on most recent published financial statements
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Valuation
Check real value of public entities based on technical and fundamental data
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Global Correlations
Find global opportunities by holding instruments from different markets
Is Autolus Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Autolus Therapeutics. If investors know Autolus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Autolus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.20)
Revenue Per Share
0.01
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.25)
Return On Equity
(1.02)
The market value of Autolus Therapeutics is measured differently than its book value, which is the value of Autolus that is recorded on the company's balance sheet. Investors also form their own opinion of Autolus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Autolus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Autolus Therapeutics' market value can be influenced by many factors that don't directly affect Autolus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Autolus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Autolus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Autolus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.